[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # $xers XERS ecosystem sees major activity with the upcoming Xpad launch driving demand, while community members actively accumulate XERS and KOKO. However, a significant $218M long-term debt remains a key concern. ### About $xers XERS is a cryptocurrency project focused on a launchpad platform, with an ecosystem including KOKO and DEF1. ### Insights - $xers sentiment near a 52-week low at XX. - $xers creators is up XXXXX% from the previous week. - $xers engagements is up XXXXX% from the previous week. - $xers posts created is up XXX% from the previous week. ### Engagements: XXXXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$xers/time-series/interactions.tsv) Current Value: XXXXX Daily Average: XXXXX X Week: XXXXX +62% X Month: XXXXXX -XX% X Months: XXXXXXXXX -XX% X Year: XXXXXXXXX -XX% 1-Year High: XXXXXXX on 2025-03-06 1-Year Low: XX on 2025-12-09 Engagements by network (24h): X: XXXXX ### Mentions: XX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$xers/time-series/posts_active.tsv) Current Value: XX Daily Average: XXX X Week: XXX -XXXX% X Month: XXX -XX% X Months: XXXXX +29% X Year: XXXXX +106% 1-Year High: XXX on 2025-06-28 1-Year Low: XX on 2025-03-02 Mentions by network (24h): X: XXX ### Creators: XX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$xers/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $xers in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX X Week: XX +11% X Month: XXX +1.40% X Months: XXXXX +353% X Year: XXXXX +213% 1-Year High: XXX on 2025-06-28 1-Year Low: XX on 2025-02-24 The most influential creators that mention $xers in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@Top_Trader12](/creator/twitter/Top_Trader12) | X | XX | X | XX | | [@sarah_poun1015](/creator/twitter/sarah_poun1015) | X | XX | X | X | | [@big_oinker](/creator/twitter/big_oinker) | X | XXXXX | X | X | | [@andrazz_](/creator/twitter/andrazz_) | X | XXXXX | X | X | | [@Iam__Mouni](/creator/twitter/Iam__Mouni) | X | XXX | X | X | [View More](/list/creators/$xers/100) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$xers/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XX% -XX% X Month: XX% -XX% X Months: XX% -XX% X Year: XX% -XX% 1-Year High: XXX% on 2025-01-21 1-Year Low: XX% on 2025-03-03 Most Supportive Themes: - Xpad Launch: (45%) The upcoming launch of Xpad is a major catalyst driving demand and interest in the XERS ecosystem. - Ecosystem Interconnectedness: (35%) The strong links between XERS, KOKO, and DEF1 are highlighted, showing a cohesive and mutually beneficial environment. - Community Accumulation: (20%) Community members are actively buying XERS and KOKO, indicating strong belief and investment in the project's future. Most Critical Themes: - Long-Term Debt: (9%) A significant concern is the $218M long-term debt, with suggestions for offerings to mitigate this issue. ### Top $xers Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$XERS Xeris Biopharma initiated with an Overweight at Barclays. Barclays initiated coverage of Xeris Biopharma with an Overweight rating and $X price target. The firm rolled out coverage on the specialty pharmaceuticals industry with a neutral view saying investor sentiment is improving as companies shift focus to innovation margin expansion and de-leveraging. The group's pricing headwinds are easing while debt leverage is coming down the analyst tells investors in a research note. Barclays sees "plenty of opportunity" as the sector "remains in a transition phase."" [X Link](https://x.com/RevShark/status/1998380175675822186) [@RevShark](/creator/x/RevShark) 2025-12-09T13:12Z 31.3K followers, 2631 engagements "$XERS Barclays initiates coverage of Xeris Biopharma with an Overweight rating and $X price target" [X Link](https://x.com/BiotechAnalysst/status/1998373863688929692) [@BiotechAnalysst](/creator/x/BiotechAnalysst) 2025-12-09T12:47Z 4534 followers, XXX engagements "$XEM $XERS 🙋♂ Guys Don't miss the next move in a few hours. 📊➡" [X Link](https://x.com/sarah_poun1015/status/1998224429269328286) [@sarah_poun1015](/creator/x/sarah_poun1015) 2025-12-09T02:53Z XX followers, XX engagements "$WYNN -Stifel raises Wynn Resorts target to $XXX from $XXX Buy -Jefferies to $XXX from $XXX Buy -JPMorgan to $XXX from $XXX Overweight -Macquarie maintains $XXX target Outperform - $XERS -Barclays initiates Xeris Biopharma coverage at Overweight $X target -" [X Link](https://x.com/MarcJacksonLA/status/1998214878457368589) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-12-09T02:15Z 7635 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
XERS ecosystem sees major activity with the upcoming Xpad launch driving demand, while community members actively accumulate XERS and KOKO. However, a significant $218M long-term debt remains a key concern.
XERS is a cryptocurrency project focused on a launchpad platform, with an ecosystem including KOKO and DEF1.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX +62%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-03-06
1-Year Low: XX on 2025-12-09
Engagements by network (24h): X: XXXXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXX -XX%
X Months: XXXXX +29%
X Year: XXXXX +106%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-03-02
Mentions by network (24h): X: XXX
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $xers in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX +11%
X Month: XXX +1.40%
X Months: XXXXX +353%
X Year: XXXXX +213%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-02-24
The most influential creators that mention $xers in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Top_Trader12 | X | XX | X | XX |
| @sarah_poun1015 | X | XX | X | X |
| @big_oinker | X | XXXXX | X | X |
| @andrazz_ | X | XXXXX | X | X |
| @Iam__Mouni | X | XXX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-01-21
1-Year Low: XX% on 2025-03-03
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$XERS Xeris Biopharma initiated with an Overweight at Barclays. Barclays initiated coverage of Xeris Biopharma with an Overweight rating and $X price target. The firm rolled out coverage on the specialty pharmaceuticals industry with a neutral view saying investor sentiment is improving as companies shift focus to innovation margin expansion and de-leveraging. The group's pricing headwinds are easing while debt leverage is coming down the analyst tells investors in a research note. Barclays sees "plenty of opportunity" as the sector "remains in a transition phase.""
X Link @RevShark 2025-12-09T13:12Z 31.3K followers, 2631 engagements
"$XERS Barclays initiates coverage of Xeris Biopharma with an Overweight rating and $X price target"
X Link @BiotechAnalysst 2025-12-09T12:47Z 4534 followers, XXX engagements
"$XEM $XERS 🙋♂ Guys Don't miss the next move in a few hours. 📊➡"
X Link @sarah_poun1015 2025-12-09T02:53Z XX followers, XX engagements
"$WYNN -Stifel raises Wynn Resorts target to $XXX from $XXX Buy -Jefferies to $XXX from $XXX Buy -JPMorgan to $XXX from $XXX Overweight -Macquarie maintains $XXX target Outperform - $XERS -Barclays initiates Xeris Biopharma coverage at Overweight $X target -"
X Link @MarcJacksonLA 2025-12-09T02:15Z 7635 followers, XXX engagements
/topic/$xers